Recursion Pharmaceuticals, Inc. RXRX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.62B.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s market capitalization?
- Recursion Pharmaceuticals, Inc. (RXRX) reported market capitalization of $1.62B in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s market capitalization decreased by 23.7% year-over-year, from $2.13B to $1.62B.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s market capitalization has grown at a -7.6% compound annual growth rate (CAGR), from $2.92B to $2.13B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.